Company Description
Sky Centy Invt (OTC Link: SKYI) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.7M.
SKYI has gained 0.0% over the past year. Shares last traded at $0.3200.
For FY2025, Sky Centy Invt reported revenue of $76K with net income of -$117K. The company operates at a net profit margin of -153.6%.
This page collects what Stock Titan holds for SKYI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sky Centy Invt (SKYI) stock last closed at $0.3200. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $1.7M, SKYI is classified as a micro-cap stock with approximately 6.9M shares outstanding.
SKYI Rankings
Latest News
Sky Centy Invt has 5 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include AI. View all SKYI news →
SEC Filings
Sky Centy Invt has filed 5 recent SEC filings, including 3 Form 10-Q, 1 Form 8-K, 1 Form 10-K. The most recent filing was submitted on July 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SKYI SEC filings →
Financial Highlights
Sky Centy Invt generated $76K in revenue in FY2025, retaining a 32.1% gross margin, operating income reached -$117K (-152.8% operating margin), and net income was -$117K, reflecting a -153.6% net profit margin. The company generated $46K in operating cash flow. With a current ratio of 0.01, short-term liquidity bears monitoring.
Upcoming Events
Sleep Quality API launch
Sky Centy Invt has 1 upcoming scheduled event. The next event, "Sleep Quality API launch", is scheduled for August 1, 2026 (in 2 days). Investors can track these dates to stay informed about potential catalysts that may affect the SKYI stock price.
Short Interest History
Short interest in Sky Centy Invt (SKYI) currently stands at 879 shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since July 2025, short interest has increased by 2830.0%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Sky Centy Invt (SKYI) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
SKYI Company Profile & Sector Positioning
Sky Centy Invt (SKYI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SKYI often look at related companies in the same sector, including Noveris Health Sciences Inc (MYCOF), North Amern Cannabis Hldgs Inc (USMJ), Branded Legacy Inc (BLEG), Real Brands (RLBD), and Pazoo Inc (PZOO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SKYI's relative position within its industry.